University of Strathclyde
A MAP2K7 genetic mouse model as an investigative tool of the cognitive and behavioural deficits in schizophrenia
Abstract
dc:description.abstractSchizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain.
Degree
thesis:*- Name dc:type.qualificationname
- mres
- Level dc:type.qualificationlevel
- masters-pg
- Grantor dc:publisher.institution
- University of Strathclyde
- Year dc:date.issued
- 2013
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ivanova, Natalja
Rights
- Licence dc:rights.uri
Identifiers
dc:identifier.*- Identifier
- T13640